betaQuant for ASCVD

Question 1

What is the cause of ASCVD?

A. Viral infection
B. Plaque buildup in arterial walls, which narrows or blocks blood flow
C. Low blood pressure
D. Muscle damage

Answer 1

Plaque buildup in arterial walls, which narrows or blocks blood flow

Question 2

What is the test/tool used in this presentation?

A. PCR assay
B. Beta-Quantification (Ultracentrifugation)
C. ELISA
D. MRI

Answer 2

Beta-Quantification (Ultracentrifugation)

Question 3

What is being measured by this tool?

A. DNA mutations
B. Cholesterol content within specific density ranges (LDL-C)
C. Blood pressure
D. Heart rate

Answer 3

Cholesterol content within specific density ranges (LDL-C)

Question 4

What is the “direct target” of the tool?

A. Tumor cells
B. Lipoprotein particles separated by density
C. Viral RNA
D. Neurons

Answer 4

Lipoprotein particles separated by density

Question 5

What is one conclusion the tool CAN support?

A. The exact number of LDL particles
B. Accurate measurement of LDL-C concentration in complex lipid profiles
C. Direct causation of ASCVD
D. Genetic cause of disease

Answer 5

Accurate measurement of LDL-C concentration in complex lipid profiles

Question 6

What is one conclusion the tool CANNOT support?

A. Measurement of cholesterol levels
B. Differentiation of LDL-C from IDL-C and Lp(a)
C. Use as a reference laboratory method
D. Detection of lipid fractions

Answer 6

Differentiation of LDL-C from IDL-C and Lp(a)

Question 7

Which statement represents an overreach of the tool’s capabilities?

A. The tool quantifies LDL-C in the bottom fraction
B. The tool can distinguish all lipoprotein subclasses precisely
C. The tool is useful for complex lipid profiles
D. The tool is a gold standard reference method

Answer 7

The tool can distinguish all lipoprotein subclasses precisely

Question 8

A researcher uses beta-quantification to measure LDL-C in a patient with hypertriglyceridemia. What is a justified conclusion?

A. The patient’s LDL particle number is known
B. The measured LDL-C reflects cholesterol in the bottom fraction after removing VLDL
C. The patient’s ASCVD risk is fully determined
D. The exact lipoprotein subtype distribution is known

Answer 8

The measured LDL-C reflects cholesterol in the bottom fraction after removing VLDL